Randomized, double-blind, placebo, and risperidone-controlled study of lurasidone in the treatment of schizophrenia: Results of an inconclusive 6-week trial.
Higuchi T, Iyo M, Kwon JS, Chou YH, Chen HK, Chen JY, Chen TT, Huang SY, Lee JS, Saeki Y, Tanaka H, Wang TS, Wu BJ, Katoh T, Ishigouoka J.
Higuchi T, et al. Among authors: chen tt, chen jy, chen hk.
Asia Pac Psychiatry. 2019 Sep;11(3):e12354. doi: 10.1111/appy.12354. Epub 2019 Mar 25.
Asia Pac Psychiatry. 2019.
PMID: 30912222
Clinical Trial.